End of Day Message

LONDON, 06 Feb. 2026 (GLOBE NEWSWIRE) — This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved

Agomab Announces Pricing of Initial Public Offering

ANTWERP, Belgium, February 5, 2026 (GLOBE NEWSWIRE) – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with

End of Day Message

LONDON, 05 Feb. 2026 (GLOBE NEWSWIRE) — This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved

Scroll to Top